Shandong Jincheng Pharmaceutical And Chemical Co., Ltd.

Jincheng Pharma: Founded in 2004, has the registered capital of 393 million, is the first GEM listed company of pharmaceutical intermediates field.Is a modern Medical Health Group with a full industrial chain, which covering cephalosporin pharmaceutical intermediates, specialty raw materials and terminal preparations, and realized two strategic transformations from pharmaceutical and chemical industries to biopharmaceuticals and then to terminal preparations.Has four chemical companies (three cephalosporin intermediate companies and one environmental protection company) Jincheng Pharmaceutical and Chemical, Huihai Pharmaceutical & Chemical, Kerui Chemical, Huirui Environmental Protection;Has 2 APIs and bio companies: Jincheng Bio, Jincheng Taier BranchHas 3 preparation companies: Beijing Jincheng Taier Pharmaceutical, Shanghai Jincheng Pharmaceutical, Guangdong Jincheng Jinsu PharmaceuticalMore than 20 other holding companies in the field of new materials, investment, medical equipment, pharmaceutical business, and health care products.Honours and Awards:Won titles such as National Science and Technology Progress AwardMost Listed Company Respected by InvestorsBest Listed Company on the Growth Enterprise Market Top 100 Chinese Pharmaceutical Industry-We are offering Biopharmaceuticals, API, intermediates, and CRO delivering comprehensive solutions to customers from the Pharmaceutical industry.-Have the capacity of 260 tons of glutathione API production. Over 70% of global market share.-Searching for new suppliers of APIs for our FDF projects.-Producing high-quality Cephalosporin preparations, Jincheng has strategic cooperations with High-quality API suppliers like ACS DOBFAR.